Alnylam Pharmaceuticals, Inc. (ALNY)
404.24
-10.96
(-2.64%)
USD |
NASDAQ |
Dec 10, 16:00
406.00
+1.76
(+0.43%)
After-Hours: 17:22
Alnylam Pharmaceuticals Free Cash Flow: 221.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| Glaukos Corp. | -27.61M |
| Bristol Myers Squibb Co. | 15.30B |
| BridgeBio Pharma, Inc. | -597.61M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 325.11M |
| Cash from Investing (Quarterly) | 501.11M |
| Cash from Financing (Quarterly) | -448.35M |
| Free Cash Flow Per Share (Quarterly) | 2.279 |
| Free Cash Flow to Equity (Quarterly) | 279.39M |
| Free Cash Flow to Firm (Quarterly) | 359.62M |
| Free Cash Flow Yield | 0.42% |